Sort
15,440 grants matching “organoids”
Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity
$468,128Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity
$468,128Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity
$468,128Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
The selective advantage of mismatch repair loss in colonic stem cells
$468,099Christopher D. Heinen · University Of Connecticut Sch Of Med/Dnt · R01 · FY2023 · CA
Shifting immunodominance of humoral immunity against influenza viruses
$468,000Jenna Guthmiller · University Of Colorado Denver · DP2 · FY2025 · AI
Discovery of apoE4 modulators for Alzheimerâs disease therapy
$467,938Yonghe Li · Mayo Clinic Jacksonville · R01 · FY2022 · AG
Interferon-inducible cell-intrinsic host defense against Chlamydia trachomatis
$467,900Joern Coers · Duke University · R01 · FY2020 · AI
Metaplastic Tuft Cells in Pancreatic Cancer
$467,825Howard C Crawford · Henry Ford Health System · R01 · FY2021 · CA
Core 1: Human Cell Models of Aging Core
$467,714Fred H Gage · Salk Institute For Biological Studies · P30 · FY2023 · AG
Single-cell mitochondrial mutation lineage tracing of non-dysplastic and dysplastic Barrett's esophagus
$467,659Sydney Shaffer · University Of Pennsylvania · R01 · FY2024 · DK
Regulation of oncogenic Akt ubiquitination and activation by diverse mechanisms in cancer
$467,627Hui-Kuan Lin · Duke University · R01 · FY2025 · CA
Project 1: Targeting autophagy for the treatment of KRAS-mutant PDAC
$467,623Channing J Der · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
Project 2 - Protein Ubiquitylation in Esophageal Cancer
$467,535J. Alan Diehl · Columbia University Health Sciences · P01 · FY2022 · CA
Estrogen Receptor and NFkB Crosstalk in Breast Cancer
$467,442Jonna Frasor · University Of Illinois At Chicago · R01 · FY2023 · CA
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2018 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2019 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2022 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1
$467,320Teresa Davoli · New York University School Of Medicine · R37 · FY2024 · CA
PROSPECT - Stem cell models
$467,310Omer Yilmaz · Massachusetts Institute Of Technology · OT2 · FY2025 · CA
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
$467,258Xiaoqi Liu · University Of Kentucky · R01 · FY2021 · CA
Role of the renal organic anion transporter OAT1 in metabolism and physiology
$467,249Sanjay K Nigam · University Of California, San Diego · R01 · FY2022 · GM
Biology of AR+ prostate cancer metastases and the role of the microenvironment
$467,174Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
The Role of EBI3 in Regulating Gastritis and Gastric Carcinogenesis
$467,031Richard J Dipaolo · Saint Louis University · R01 · FY2020 · DK